Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT01731444
PHASE1

Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury

Sponsor: University of Manitoba

View on ClinicalTrials.gov

Summary

The standard of care for treatment of burn injury is to inject a solution of epinephrine under the skin of the injured site in order to reduce blood loss during skin grafting. This solution of epinephrine has been shown to have effects on the body outside the donor site. Some people have increases in heart rate and blood pressure. We will study the effect of a phenylephrine solution in place of an epinephrine solution to control blood loss. We think that phenylephrine will help decrease blood loss and not change blood pressure or heart rate. The injured area will be injected under the skin and a skin graft will be taken in the same way as we usually do. The only change will be the use of phenylephrine in the solution instead of epinephrine. Our goal is to find whether or not phenylephrine or epinephrine solution results in a reduction of blood loss without affecting the rest of the body.

Official title: Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury - A Randomized Control Trial

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2014-12-01

Completion Date

2027-12

Last Updated

2024-12-05

Healthy Volunteers

No

Interventions

DRUG

Phenylephrine

Locations (1)

University of Manitoba

Winnipeg, Manitoba, Canada